Plant-based vaccines utilize plants as bioreactors for antigens which can help stimulate human immune response. The key advantages of plant-based vaccine production are possibility of low-cost oral delivery, ease of scalability, thermostability without any cold chain requirement and rapid production. With rising prevalence of infectious diseases and emerging need for effective vaccination programs globally, alternative platforms for vaccine manufacturing are gaining prominence.

The global Plant-based Vaccines Market is estimated to be valued at US$ 98.19 Mn  in 2023 and is expected to exhibit a CAGR of 9.6%  over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity: Alternative Vaccine Manufacturing Platforms

One of the major market opportunities for plant-based vaccines is the scope offered by the platform for alternative vaccine manufacturing. Traditional methods of vaccine production are often costly and time consuming. Plant-based expression system provides possibility of rapid, inexpensive and scalable production which is highly beneficial for developing and stockpiling vaccines for emerging infectious diseases. Furthermore, plant-based vaccines can overcome issues like cold chain requirements associated with some existing vaccines. Their thermostability and ease of oral delivery without need of medical professionals make plant-based vaccines a promising alternative for improving vaccination drives globally especially in remote and low-income regions. The alternative manufacturing platform offered by plant-based vaccines is thus expected to witness increased adoption over the forecast period.

Porter's Analysis
Threat of new entrants: The plant-based vaccines market requires significant research and development investments as well as manufacturing infrastructure. These high entry barriers reduces the threat of new entrants.
Bargaining power of buyers: Buyers have moderate bargaining power in this market as plant-based vaccines have limited alternatives and buyers cannot substitute them easily.
Bargaining power of suppliers: Suppliers have moderate bargaining power as raw materials for plant-based vaccines such as plants are available from multiple sources.
Threat of new substitutes: Threat of new substitutes is low as alternatives like DNA and attenuated live bacterial vaccines have their own limitations.
Competitive rivalry: The market is competitive with key players focusing on R&D to develop novel plant-based vaccines.

SWOT Analysis
Strength: Plant-based vaccines offer benefits like low-cost mass production, thermostability without cold chain requirement and safe method of delivery without needle prick.
Weakness: Regulatory compliance and acceptance remains a challenge. Manufacturing at scale and ensuring product quality needs further development.
Opportunity: Rising prevalence of infectious diseases and growing demand for cost-effective vaccines present significant opportunities.
Threats: Technical failures and setbacks during clinical trials and regulatory approvals pose threats to market growth.

Key Takeaways
The global Plant-Based Vaccines Market Share is expected to witness high growth during the forecast period of 2023 to 2030. The market size is projected to reach US$ 98.19 Mn  by 2024.
Regional analysis shows that North America dominates currently due to strong government support and presence of leading players. However, Asia Pacific is expected to grow at fastest pace due to rising healthcare expenditure, large patient pool and increasing research initiatives in countries like China and India.
Key players operating in the plant-based vaccines market are Medicago, Inc., IBIO, Inc., Icon Genetics GmbH, Lumen Bioscience, Inc., British American Tobacco Plc., Creative Biolabs, Inc., Leaf Expression Systems Ltd., ZYUS Life Sciences Inc., PlantForm Corporation, and Infectious Disease Research Institute (IDRI). Medicago, Inc. and IBIO, Inc. hold major market share currently.

Explore more related article on this topic: https://www.newsanalyticspro.com/the-plant-based-vaccines-market-demand-analysis/